RecruitingNCT06725706

Beta Amyloid PET/CT in Various Aβ-Related Disease

Sponsor

Tianjin Medical University

Enrollment

500 participants

Start Date

Sep 1, 2012

Study Type

OBSERVATIONAL

Conditions

Beta-Amyloid Neurodegenerative Diseases Amyloid

Summary

To evaluate the potential usefulness of 18F-92/AV45, 11C-PIB positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study uses a specialized PET/CT scan that detects amyloid beta (Aβ) — a protein linked to Alzheimer's disease — to see if the same protein also plays a role in certain cancers and other diseases. **You may be eligible if...** - Age 18 or older - Have a suspected, newly diagnosed, or previously treated cancer or Aβ-related condition - Have been scheduled for an amyloid beta PET/CT scan as part of your clinical workup - Able to provide informed consent **You may NOT be eligible if...** - Are pregnant or breastfeeding - Have an allergy to the imaging agent used in the scan - Have serious kidney disease preventing the scan procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.